HCP Inc. selloff overdone, says Argus

theflyonthewall.com

Argus believes that the 26% drop in HCP's stock since mid-May is unjustified, in light of the company's recent results, which the firm views as strong. Argus keeps a Buy rating on the stock.

Rates

View Comments (0)